comparemela.com

Latest Breaking News On - Bain capital life sciences investors - Page 6 : comparemela.com

Cantor Fitzgerald Reiterates Overweight Rating for Annexon (NASDAQ:ANNX)

Cantor Fitzgerald reissued their overweight rating on shares of Annexon (NASDAQ:ANNX – Free Report) in a research report report published on Wednesday, Benzinga reports. ANNX has been the subject of several other research reports. Wells Fargo & Company lifted their target price on shares of Annexon from $11.00 to $12.00 and gave the company an […]

Annexon (NASDAQ:ANNX) Given Buy Rating at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of Annexon (NASDAQ:ANNX – Free Report) in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a $16.00 target price on the stock. ANNX has been the subject of a number of other research reports. HC Wainwright restated a buy rating and […]

Cabaletta Bio (NASDAQ:CABA) Receives Overweight Rating from Cantor Fitzgerald

Cabaletta Bio (NASDAQ:CABA) Receives Overweight Rating from Cantor Fitzgerald
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

X4 Pharmaceuticals (NASDAQ:XFOR) Earns Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of X4 Pharmaceuticals (NASDAQ:XFOR – Free Report) in a research note released on Friday, Benzinga reports. The brokerage currently has a $3.00 price objective on the stock. Separately, B. Riley lowered X4 Pharmaceuticals from a buy rating to a neutral rating and lowered their target price for […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.